Literature DB >> 10779386

Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.

Z Yu1, L M Huse, P Adler, L Graham, J Ma, D C Zeldin, D L Kroetz.   

Abstract

Epoxyeicosatrienoic acids (EETs) are major products of cytochrome P450 (CYP)-catalyzed metabolism of arachidonic acid in the kidney. The potent effect of EETs on renal vascular tone and tubular ion and water transport implicates their role in the regulation of renal function and blood pressure. The present study was designed to test the hypothesis that CYP-catalyzed EET formation was altered in the spontaneously hypertensive rat (SHR) kidney. The formation of 14,15- and 11,12-EET was approximately 2-fold higher in incubations of arachidonic acid with SHR renal cortical microsomes relative to microsomes from normotensive Wistar-Kyoto (WKY) rats. This was consistent with increased expression of a CYP2J2 immunoreactive protein in the SHR cortex and outer medulla. In contrast, there was no significant difference in the levels of the CYP2E and CYP2C epoxygenases in SHR and WKY kidneys. Protein and RNA analysis suggests that the CYP2J2 immunoreactive protein that is overexpressed in the SHR kidney is distinct from the known rat CYP2J isoforms. EET formation also was documented in vivo from measurements of urinary EET excretion. Importantly, the excretion rates of 14,15-, and 11,12-EETs were 2.5- and 1.8-fold higher, respectively, in SHR than WKY kidney. These studies provide both in vitro and in vivo evidence for increased EET formation in the SHR kidney and identify a novel CYP2J2 immunoreactive protein that is differentially expressed in the hypertensive kidney. In light of the known biological properties of the EETs, these findings may be important in elucidating the mechanisms that control renal vascular tone and tubular ion transport in the SHR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779386

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  20 in total

1.  A novel vascular EET synthase: role of CYP2C7.

Authors:  Dong Sun; Houli Jiang; Hongyan Wu; YangMing Yang; Gabor Kaley; An Huang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-21       Impact factor: 3.619

2.  Epoxyeicosatrienoic acids and soluble epoxide hydrolase: potential therapeutic targets for inflammation and its induced carcinogenesis.

Authors:  Stephanie Norwood; Jie Liao; Bruce D Hammock; Guang-Yu Yang
Journal:  Am J Transl Res       Date:  2010-07-22       Impact factor: 4.060

Review 3.  Epoxygenase metabolites. Epithelial and vascular actions.

Authors:  J D Imig
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

4.  Role of epoxyeicosatrienoic acids as autocrine metabolites in glutamate-mediated K+ signaling in perivascular astrocytes.

Authors:  Haruki Higashimori; Víctor M Blanco; Vengopal Raju Tuniki; John R Falck; Jessica A Filosa
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-15       Impact factor: 4.249

5.  Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.

Authors:  Yingmei Liu; Heather K Webb; Hisayo Fukushima; Janine Micheli; Svetlana Markova; Jean L Olson; Deanna L Kroetz
Journal:  J Pharmacol Exp Ther       Date:  2012-03-13       Impact factor: 4.030

Review 6.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

7.  Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity.

Authors:  Rolf M Nüsing; Horst Schweer; Ingrid Fleming; Darryl C Zeldin; Markus Wegmann
Journal:  Am J Physiol Renal Physiol       Date:  2007-05-09

Review 8.  Roles of the epoxygenase CYP2J2 in the endothelium.

Authors:  Ara Askari; Scott J Thomson; Matthew L Edin; Darryl C Zeldin; David Bishop-Bailey
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-03-06       Impact factor: 3.072

9.  Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Authors:  Helen E Smith; J P Jones; Thomas F Kalhorn; Federico M Farin; Patricia L Stapleton; Connie L Davis; James D Perkins; David K Blough; Mary F Hebert; Kenneth E Thummel; Rheem A Totah
Journal:  Pharmacogenet Genomics       Date:  2008-11       Impact factor: 2.089

10.  Increased blood pressure in mice lacking cytochrome P450 2J5.

Authors:  Krairerk Athirakul; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Jixiang Ma; Yun Zhao; John F Couse; Raymond Quigley; David R Harder; Xueying Zhao; John D Imig; Theresa L Pedersen; John W Newman; Bruce D Hammock; Alan J Conley; Kenneth S Korach; Thomas M Coffman; Darryl C Zeldin
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.